Navigation Links
CNA Presents New Data on Sutter's Medical Redlining
Date:10/25/2007

St. Luke's Closure to Have Disproportionate Impact On Latinos, Other

Medically Underserved Groups

OAKLAND, Calif., Oct. 25 /PRNewswire/ -- Sutter Health's planned closure of St. Luke's Hospital in San Francisco will have a particularly adverse impact on the city's Latino community, as evidenced by new state data released today by the California Nurses Association/National Nurses Organizing Committee. CNA/NNOC presented the data at a San Francisco press conference opposing Sutter's plans to end all hospital services at St. Luke's by 2009.

Sutter plans to transfer much of the current in-patient hospital care to another facility across town, California Pacific Medical Center. That process gets underway as of November 11 when Sutter will close newborn intensive care and children's facilities at St. Luke's.

"Latinos and other medically underserved populations will suffer an inordinate, disproportionate, and discriminatory impact from this unnecessary closure," said Bonnie Castillo, RN, CNA/NNOC's Sutter division director. "Sutter has made it apparent that it would prefer to have a more high income patient base, and is slamming the doors on a community that desperately needs this hospital. Medical redlining should have no place in San Francisco."

A CNA/NNOC analysis of state data, from the Office of Statewide Health Planning and Development, shows a huge disparity between the demographics of patients served by St. Luke's and CPMC.

-- 40 percent of in-patient hospital discharges at St. Luke's are Hispanic

patients -- compared to just 1 percent of CPMC discharges.

-- 54 percent of emergency room visits at St. Luke's are Hispanic or

African-American patients -- compared to just 8 percent of ER visits at

CPMC.

The state data also demonstrates a stark divergence in income levels.

-- 42 percent of ER visits at St. Luke's are billed to Medi-Cal --

compared t
'/>"/>

SOURCE California Nurses Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
2. IDM Pharma Presents Preliminary Results of Melanoma Vaccine Clinical Trial
3. Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade
4. Childrens Hospital Boston Presents at the Society for Adolescent Medicine Annual Meeting
5. Monogram Presents Results of First ETag Breast Cancer Studies
6. Novagali Pharma Presents Phase III Clinical Trial of Vekacia(R) for Vernal Keratoconjunctivitis
7. Check if your “Favourite medical web-site” is indulging in Quackey
8. Teens turning to Internet for medical queries
9. Robots craft medical history
10. NBE to conduct test for medical students from abroad
11. Air pollution combined with greater medical needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2008)...- Inc. Magazine recently included,Connolly Consult...ing,private companies in the country. The list is ...segment of the economy -- America,s,independent-mi...ies,represent the backbone of the U.S. economy., ...03/NY36880LOGO ), Connolly Consulting,s consiste...
(Date:10/3/2008)... Discrimination; Recognizes,Importance of Mental H.../PRNewswire-USNewswire/ -- Mental Health,America t...approval of a,mental health parity legislation tha...ion against Americans with mental health and subst...lans., The legislation, which recognizes the impo...
(Date:10/3/2008)...search Foundation(R) Collection of, Bouquets to T...Research, LOS ANGELES, Oct. 3 /PRNewswire/ -- Tel...g only hand-arranged, hand-delivered floral,arrang...nth-long,collaboration with The City of Hope, John... Cancer Center in southern California and national...
(Date:10/3/2008)...- As the population ages, a big,question employers...e the,financial crunch of an illness?", In most c...eck to,paycheck and now need two incomes to provid... spouses becomes critically ill and unable to work...ut the healthy,employee/spouse is strained by the ...
Breaking Medicine News(10 mins):Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 2Health News:Mental Health America Hails Approval of Federal Parity Legislation 3Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Can Your Employees Survive the Financial Crunch of an Illness? 2
...A large number of doctors in Portugal were refusin...tting abortions up to the 10th week of pregnancy ....ctors" and press reports indicated at least nine p...a total of 50 could not guarantee the procedure. ...
...China will mass-produce a Cuban pesticide effectiv...n ministry said Sunday . Cuban scientists develop...ls larvae of the Aedes aegypti mosquito, the dengu...statement said. According to the agreement, China...
...A new study has examined whether a vaccine that of...asing risky behaviour , as a false sense of securi...herwise would be. While the study looks at the r... its authors suggest the research also sheds light...
...A recent research has found that a suntan is the b...fects of ultraviolet (UV) light .Researchers at th...in Boston have conducted a series of experiments a...the body from the cancerous effects of ultraviolet...
Other Medicine News:Health News:Efficacy of Lyme Disease Vaccination Examined 2
(Date:10/3/2008)...e newest study site, PHILADELPHIA, Oct. 3 /PRNews...ladelphia today received a contract to manage a ne...ldren,s Hospital will manage local,participation, ...ty, New,Jersey. The study is funded by the Nationa... approximately 1,000 families in Burlington,County...
(Date:10/2/2008)...f Rosetta Genomics, microRNA-based,Test, miRview(T...n Squamous non Small Cell Lung Cancer, With C...view(TM) Technology First Approved for Clinical us... Molecular Pathology Lab ... to Launch miRview(TM) Squamous Later This Ye...
(Date:10/2/2008)...stCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; T...ed on,endocrine therapy and oncology, today report... recruitment for its Phase 2 trial in ovarian canc...hormone (LHRH) agonist,linked to doxorubicin. The ...uitment was taken following recent first stage dat...
(Date:10/1/2008)...ingual lozenge) developed to be the first sleep a... when patients awaken and have difficulty .../- Transcept Pharmaceuticals,Inc., a...announced today,that it has submitted a New Drug A...tration (FDA) for its lead product candidate, Inte...
Breaking Medicine Technology:The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 1Dawning Technologies Inc and Medical Automation Systems Inc to Develop a Business Partnership 20850 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 1Haemacure Reports on Financing Progress and Second Quarter Results 20846 2Haemacure Reports on Financing Progress and Second Quarter Results 20846 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 1US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2288 5Vaccine may double survival in patients with deadly brain tumors 20841 1Vaccine may double survival in patients with deadly brain tumors 20841 2
Straight shafts with 1 x 2 teeth and serrated handle with polished finish.
Smooth 90 degree jaws with locking screw maintain proper stretch of sleeve for securing silicone bands.
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 gauge shaft tapering to 23 gauge, 10 mm from tip. Overall length from rear rotation knob to tip.
Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge.
Medicine Products: